The evolution of minimally invasive devices for removal of ICHs and the earlier delivery of patients for medical attention may have a great impact on the management of hypertensive hemorrhage. It is hoped that development of neuroprotective agents effective in both ischemic and hemorrhagic stroke, which can be administered prior to obtaining CT scans, will extend the therapeutic window for obtaining benefit from surgical evacuation to prevent the sequelae of hemorrhage, which lead to deterioration of neurologic function and lessen the chance for survival.
|Original language||English (US)|
|Number of pages||8|
|Journal||Neurosurgery clinics of North America|
|State||Published - Jun 9 1997|
ASJC Scopus subject areas
- Clinical Neurology